Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP64144.RAPFVtKe3CgaxbX2TmD5h-FHnnJ-CZ5zh2_3XtrQn3Dbs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP64144.RAPFVtKe3CgaxbX2TmD5h-FHnnJ-CZ5zh2_3XtrQn3Dbs130_assertion type Assertion NP64144.RAPFVtKe3CgaxbX2TmD5h-FHnnJ-CZ5zh2_3XtrQn3Dbs130_head.
- NP64144.RAPFVtKe3CgaxbX2TmD5h-FHnnJ-CZ5zh2_3XtrQn3Dbs130_assertion description "[The response rates at the 3rd and 7th days after medication did not differ with either the drug group or the dopamine transporter polymorphism. Relatively low doses of risperidone and haloperidol exhibited similar efficacies, and dopamine transporter poly]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64144.RAPFVtKe3CgaxbX2TmD5h-FHnnJ-CZ5zh2_3XtrQn3Dbs130_provenance.
- NP64144.RAPFVtKe3CgaxbX2TmD5h-FHnnJ-CZ5zh2_3XtrQn3Dbs130_assertion evidence source_evidence_literature NP64144.RAPFVtKe3CgaxbX2TmD5h-FHnnJ-CZ5zh2_3XtrQn3Dbs130_provenance.
- NP64144.RAPFVtKe3CgaxbX2TmD5h-FHnnJ-CZ5zh2_3XtrQn3Dbs130_assertion SIO_000772 15823165 NP64144.RAPFVtKe3CgaxbX2TmD5h-FHnnJ-CZ5zh2_3XtrQn3Dbs130_provenance.
- NP64144.RAPFVtKe3CgaxbX2TmD5h-FHnnJ-CZ5zh2_3XtrQn3Dbs130_assertion wasDerivedFrom gad-20150221 NP64144.RAPFVtKe3CgaxbX2TmD5h-FHnnJ-CZ5zh2_3XtrQn3Dbs130_provenance.
- NP64144.RAPFVtKe3CgaxbX2TmD5h-FHnnJ-CZ5zh2_3XtrQn3Dbs130_assertion wasGeneratedBy ECO_0000203 NP64144.RAPFVtKe3CgaxbX2TmD5h-FHnnJ-CZ5zh2_3XtrQn3Dbs130_provenance.